Article Text

Download PDFPDF
Review: in alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving

Statistics from


  • Sources of funding US National Institute on Alcohol Abuse and Alcoholism, and the US Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development Service and Substance Use Disorder Quality Enhancement Research Initiative.


  • Competing interests For the past 5 years, MS has received grants or has worked as a consultant for Reckitt Benckiser, Lilly, Astra Zeneca, Roche, Essex, Lundbeck, Sanofi and Aventis.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.